Comprehensive analysis of human pancreatic islets using flow and laser scanning cytometry
- PMID: 18374064
- PMCID: PMC4860356
- DOI: 10.1016/j.transproceed.2008.01.037
Comprehensive analysis of human pancreatic islets using flow and laser scanning cytometry
Abstract
Assessing islet cellular composition and beta cell viability using Flow Cytometry (FC) and Laser Scanning Cytometry (LSC) may aid in determining the transplant quality of islets. Human islets (2500 IEQ, n = 44, purity >or=80%) dissociated into a single cell suspension were stained with ductal marker CA19, with Newport Green (NG) and FluoZin3 (FL3) for beta-cell identification, with TMRE to assess mitochondrial membrane potential, with DAPI to identify live vs. dead cells, and with Annexin-V/DAPI to differentiate apoptotic and necrotic cells. For LSC, cell preparations (n = 9) were stained for insulin (beta-cells), glucagon (alpha-cells), somatostatin (delta cells), and pancreatic polypeptide (ppp cells). Fluorescence microscopy (EtBr/FDA) and insulin response were also measured. DAPI- staining was 73.78% +/- 1.37, while EtBr/FDA was 96% +/- 0.48. 52.5% +/- 3.73 of all cells were NG+, of which 58.08% +/- 2.61 were NG+/TMRE+. Annexin-V/DAPI staining (n = 26) showed 13.8% +/- 0.89 apoptotic, 27.2% +/- 2.0 necrotic, and 51.9% +/- 2.22 live cells. 26.0% +/- 5.19 of cells were CA19 positive (n = 17), of which 45.5% +/- 4.37 were also TMRE+, and 5.2% +/- 1.2 of the TMRE+ were also NG+/CA19+. NG and FL3 showed similar staining (n = 8). Comparison of short-term (<or=2 days) versus long-term (>or=3 days) culture showed similar TMRE+/NG+ averages, albeit lower percentages of live (36.4% vs 51.9%), and higher percentages of apoptotic (19.2% vs 13.8%) and necrotic cells (37.4% vs 27.2%) for long-term, as determined by Annexin-V staining. LSC resulted in 54.17% +/- 4.62 beta-cells, 33.33% +/- 4.16 alpha-cells, 8.75% +/- 2.5 delta-cells, and 3.75% +/- 0.79 ppp cells. There is no significant difference between insulin positive cells and NG positive cells (P <or= .55). FC and LSC provide valuable information about islet quality, which could potentially be used for evaluating islets prior to transplantation.
Similar articles
-
Quantitative assessment of β-cell apoptosis and cell composition of isolated, undisrupted human islets by laser scanning cytometry.Transplantation. 2010 Oct 27;90(8):836-42. doi: 10.1097/TP.0b013e3181f1db5d. Transplantation. 2010. PMID: 20697327 Free PMC article.
-
The effects of digestion enzymes on islet viability and cellular composition.Cell Transplant. 2012;21(4):649-55. doi: 10.3727/096368911X623826. Epub 2012 Jan 10. Cell Transplant. 2012. PMID: 22236690
-
Evaluation of isolated caprine pancreatic islets cytoarchitecture by laser scanning confocal microscopy and flow cytometry.Xenotransplantation. 2016 Mar;23(2):128-36. doi: 10.1111/xen.12220. Epub 2016 Jan 20. Xenotransplantation. 2016. PMID: 26792070
-
The potential benefit of non-purified islets preparations for islet transplantation.Biotechnol Genet Eng Rev. 2012;28:101-14. doi: 10.5661/bger-28-101. Biotechnol Genet Eng Rev. 2012. PMID: 22616483 Review.
-
Laser scanning cytometry: understanding the immune system in situ.Nat Rev Immunol. 2007 Nov;7(11):897-904. doi: 10.1038/nri2188. Nat Rev Immunol. 2007. PMID: 17917673 Review.
Cited by
-
Implication of mitochondrial cytoprotection in human islet isolation and transplantation.Biochem Res Int. 2012;2012:395974. doi: 10.1155/2012/395974. Epub 2012 May 7. Biochem Res Int. 2012. PMID: 22611495 Free PMC article.
-
Laser scanning cytometry: principles and applications-an update.Methods Mol Biol. 2013;931:187-212. doi: 10.1007/978-1-62703-056-4_11. Methods Mol Biol. 2013. PMID: 23027005 Free PMC article. Review.
-
Quantitative assessment of β-cell apoptosis and cell composition of isolated, undisrupted human islets by laser scanning cytometry.Transplantation. 2010 Oct 27;90(8):836-42. doi: 10.1097/TP.0b013e3181f1db5d. Transplantation. 2010. PMID: 20697327 Free PMC article.
-
The pancreatic β-cell transcriptome and integrated-omics.Curr Opin Endocrinol Diabetes Obes. 2014 Apr;21(2):83-8. doi: 10.1097/MED.0000000000000051. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 24526012 Free PMC article. Review.
References
-
- Shapiro AMJ, Lakey JRT, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230. - PubMed
-
- Gray D, Davalli A, et al. An historical view of the development of cellular and islet transplantation. Clinical effectiveness of islet transplantation. In: Hakim N, Stratta R, Gray D, editors. Pancreas and Islet Transplantation. Oxford: Oxford University Press; 2002. p. 305.
-
- Shapiro AMJ, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355:1318. - PubMed
-
- Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060. - PubMed
-
- Balibrea del Castillo JM, Vara Ameigeiras E, Arias-Diaz J, et al. Current status of islet transplantation. Cir Esp. 2007;81:177. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources